Author

T. Patil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

A. G. Sowalsky· 1 shared A. M. Johnson· 1 shared A. Navarro· 1 shared A. Rajan· 1 shared A. T. Le· 1 shared C. Allen· 1 shared C. Caldas· 1 shared C. H. Dampier· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. G. Sowalsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

D.-T. Hoang, G. Dinstag, L. C. Hermida, D. S. Ben-Zvi, E. Elis, K. Caley, S.-J. Sammut, S. Sinha, N. Sinha, C. H. Dampier, C. Stossel, T. Patil, A. Rajan, W. Lassoued, J. Strauss, , E. Ruppin

ENLIGHT-DeepPT predicts cancer treatment response from H&E slides by first imputing transcriptomics and then using that data to predict response across multiple therapies and cancer types.

bioRxiv · Jun 7, 2022 · PreprintCancer Biology

Adaptive immunity is required for durable responses to alectinib in murine models of EML4-ALK lung cancer

E. K. Kleczko, T. K. Hinz, T. T. Nguyen, N. J. Gurule, A. Navarro, A. T. Le, A. M. Johnson, J. Kwak, D. I. Polhac, E. T. Clambey, M. C. Weiser-Evans, T. Patil, E. L. Schenk, L. E. Heasley, R. A. Nemenoff

This paper shows that adaptive immunity enhances the durability of alectinib response in EML4-ALK lung cancer models, with CD8+ T cells playing a key role.

bioRxiv · Apr 14, 2022 · PreprintCancer Biology